Search

The Consumer Healthcare Products Association (CHPA) Educational Foundation is pleased to announce that Mary Leonard is assuming the role of foundation director.

At its fall meeting, CHPA leadership approved Amardeep Kahlon, Chief Marketing Officer and Vice President of U.S. Marketing at GSK Consumer Healthcare to serve as the new chair of the CHPA Educational Foundation’s board of directors.

The dietary supplement industry’s self-regulatory coalition, the SIDI Work Group, today released an updated version of the Standardized Information on Dietary Ingredients (SIDI TM) Protocol.

CHPA highlights the results of a recent five-state survey from the Asthma and Allergy Foundation of America, which found that consumers on the whole, prefer full access to OTC medicine containing pseudoephedrine.

New members of the Consumer Healthcare Products Association (CHPA) Board of Directors were elected at the association’s board of directors meeting, held November 17 in Washington, D.C.

CHPA, the PCPC, and their member companies are aligned with FDA, CDC, the U.S. Surgeon General, and other health professionals worldwide about the important health benefits sunscreens provide as part of a safe sun regimen.

We applaud FDA for focusing their enforcement efforts on homeopathic drug products that do not meet manufacturing standards, contain harmful ingredients, or are OTC products with prescription indications.

The dietary supplement industry’s self-regulatory coalition, the SIDI Work Group, today released an updated draft of the “Standardized Information on Dietary Ingredients (SIDI) Protocol,” and seeks feedback from industry stakeholders and regulators by July 3, 2017.

CHPA recently appointed Marina Karp as director of health policy, a newly created position responsible for helping to develop the association’s overall health policy priorities including policy research and outreach to the broader healthcare community.